A Study to Evaluate the Efficacy and Safety of Toripalimab or Placebo Combined With Chemotherapy in Treatment-naive Advanced NSCLC
Clinical trial NCT03856411 · COMPLETED
Trial details
- NCT number
- NCT03856411
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-18
- Primary completion
- 2022-08-31
- Enrollment
- 465
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.